NASDAQ_GWPH_2013
Loading viewer...
annual_report
Format: PDF annual_report
GW Pharmaceuticals' 2013 Annual Report highlights significant advancements in cannabinoid medicines, including Sativex and Epidiolex, and IPO success.
Related tags
More from GW Pharmaceuticals
View all →
Similar annual_reports from other companies
Browse all →ACADIA Pharmaceuticals 2016 Annual Meeting Proxy Statement
annual_reportannual_report
100 Pages
ACADIA Pharmaceuticals
annual_report
MTR Corporation
